{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T02:16:40Z","timestamp":1783304200348,"version":"3.54.6"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"publisher","award":["075-15-2025-598"],"award-info":[{"award-number":["075-15-2025-598"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mixed histiocytosis (MH), the coexistence of two or more histiocytic disorders in the same patient, is rare and poorly understood. Langerhans cell histiocytosis (LCH) is a clonal myeloid disorder characterized by infiltration of pathological antigen-presenting cells with morphological and phenotypic resemblance to Langerhans cells. Activating mutations of the MAPK\/ERK signaling cascade represent the principal driver of LCH pathogenesis and are also central to Erdheim-Chester disease (ECD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We present a 34-year-old patient diagnosed with a mixed form of LCH and ECD involving the kidneys, skin, bones, ENT organs, eyes, and central nervous system. The clinical phenotype included diabetes insipidus, chronic otitis externa, and suspected hereditary anemia and hemochromatosis. Tissue samples were examined using histochemical, immunohistochemical, and immunofluorescence methods, along with whole-exome sequencing (WES) of blood and skin. The patient demonstrated a partial clinical and laboratory response to targeted therapy with trametinib and desmopressin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Comparison of WES data from blood and skin revealed 71,953 shared variants consistent with likely germline origin, 3,081 somatic variants in skin, and 2,633 in blood. A low-level mosaic\n                      <jats:italic>BRAF<\/jats:italic>\n                      V600E mutation (variant allele frequency 1%) was identified in skin, in addition to pathogenic germline variants in\n                      <jats:italic>STEAP3<\/jats:italic>\n                      (c.523\u20132\u00a0A\u2009&gt;\u2009T, NM_182915.3) and\n                      <jats:italic>SLC40A1<\/jats:italic>\n                      (c.332T\u2009&gt;\u2009A, p.Met111Lys, NM_014585.6). Immunofluorescence of bone marrow trephine biopsy demonstrated heterogeneous cellular populations: sparse tryptase-positive mast cells with minimal intercellular contacts; Vimentin\n                      <jats:sup>+<\/jats:sup>\n                      CD11b\n                      <jats:sup>\u2013<\/jats:sup>\n                      CD34\n                      <jats:sup>+<\/jats:sup>\n                      (0.68%) and Vimentin\n                      <jats:sup>+<\/jats:sup>\n                      CD11b\n                      <jats:sup>+<\/jats:sup>\n                      CD34\n                      <jats:sup>\u2013<\/jats:sup>\n                      (7.78%) stromal subsets; and a predominance of CD68\n                      <jats:sup>+<\/jats:sup>\n                      cells (55.61%) over S100\n                      <jats:sup>+<\/jats:sup>\n                      cells (43.02%). Double-positive CD68\n                      <jats:sup>+<\/jats:sup>\n                      S100\n                      <jats:sup>+<\/jats:sup>\n                      cells were infrequent (2.174%), consistent with transitional stages of Langerhans cells toward LCH cells (up to 4.81%). This hybrid microenvironment paralleled the patient\u2019s systemic inflammatory activity (elevated acute-phase reactants), multi-organ involvement, and renal interstitial fibrosis\/tubular atrophy with impaired kidney function, without serological or histological evidence of vasculitis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case illustrates the histological heterogeneity and hybrid nature of MH, where canonical dendritic LCH cells coexist with macrophage-rich ECD-like infiltrate. An integrated approach involving a multidisciplinary clinical team, thorough molecular genetic testing, and the application of targeted therapy is essential for improving prognosis and quality of life in young patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-026-04379-2","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:42:42Z","timestamp":1778503362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A case of mixed histiocytosis (Erdheim-Chester disease and Langerhans cell histiocytosis) with STEAP3-associated anemia and type 4 hemochromatosis"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7894-9222","authenticated-orcid":false,"given":"Anastasiia A.","family":"Buianova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana A.","family":"Gaydina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Reznik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksim D.","family":"Iarovoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna A.","family":"Kuznetsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera A.","family":"Belova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail A.","family":"Ignatyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr A.","family":"Shatalov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanna A.","family":"Repinskaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna P.","family":"Shinkarina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artem V.","family":"Volodkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitrii A.","family":"Atiakshin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitriy O.","family":"Korostin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"4379_CR1","doi-asserted-by":"publisher","first-page":"102658","DOI":"10.1016\/j.eclinm.2024.102658","volume":"73","author":"F Pegoraro","year":"2024","unstructured":"Pegoraro F, Papo M, Cohen-Aubart F, Peyronel F, Lugli G, Trambusti I, et al. Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans cell histiocytosis). EClinicalMedicine. 2024;73:102658. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102658.","journal-title":"EClinicalMedicine"},{"issue":"12","key":"4379_CR2","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1007\/s00277-023-05501-1","volume":"102","author":"JW Dai","year":"2023","unstructured":"Dai JW, Lin H, Chang L, Li J, Zhou DB, Cao XX. The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease. Ann Hematol. 2023;102(12):3335\u201343. https:\/\/doi.org\/10.1007\/s00277-023-05501-1.","journal-title":"Ann Hematol"},{"issue":"1","key":"4379_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1080\/10428194.2020.1824070","volume":"62","author":"A Bonometi","year":"2021","unstructured":"Bonometi A, for Associazione Italiana Ricerca Istiocitosi AIRI ONLUS. The triptych of mixed histiocytosis: a systematic review of 105 cases and proposed clinical classification. Leuk Lymphoma. 2021;62(1):32\u201344. https:\/\/doi.org\/10.1080\/10428194.2020.1824070.","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"4379_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/hon.2857","volume":"39","author":"N Gulati","year":"2021","unstructured":"Gulati N, Allen CE. Langerhans cell histiocytosis: Version 2021. Hematol Oncol. 2021;39(1):15\u201323. https:\/\/doi.org\/10.1002\/hon.2857.","journal-title":"Hematol Oncol"},{"issue":"1","key":"4379_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s44313-024-00015-9","volume":"59","author":"SO Yoon","year":"2024","unstructured":"Yoon SO. Pathologic characteristics of histiocytic and dendritic cell neoplasms. Blood Res. 2024;59(1):18. https:\/\/doi.org\/10.1007\/s44313-024-00015-9.","journal-title":"Blood Res"},{"issue":"10295","key":"4379_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0140-6736(21)00311-1","volume":"398","author":"JF Emile","year":"2021","unstructured":"Emile JF, Cohen-Aubart F, Collin M, Fraitag S, Idbaih A, Abdel-Wahab O, et al. Histiocytosis Lancet. 2021;398(10295):157\u201370. https:\/\/doi.org\/10.1016\/S0140-6736(21)00311-1.","journal-title":"Histiocytosis Lancet"},{"issue":"10","key":"4379_CR7","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1158\/2159-8290.CD-19-0138","volume":"9","author":"F Halbritter","year":"2019","unstructured":"Halbritter F, Farlik M, Schwentner R, Jug G, Fortelny N, Schn\u00f6ller T, et al. Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis. Cancer Discov. 2019;9(10):1406\u201321. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0138.","journal-title":"Cancer Discov"},{"issue":"19","key":"4379_CR8","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1182\/blood.2020005209","volume":"136","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, van Halteren AGS, Lei X, Borst J, Steenwijk E, de Wit T, et al. Bone marrow-derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis. Blood. 2020;136(19):2188\u201399. https:\/\/doi.org\/10.1182\/blood.2020005209.","journal-title":"Blood"},{"issue":"8","key":"4379_CR9","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1182\/blood.2024026066","volume":"145","author":"G Abagnale","year":"2025","unstructured":"Abagnale G, Schwentner R, Ben Soussia-Weiss P, van Midden W, Sturtzel C, P\u00f6tschger U, et al. BRAFV600E induces key features of LCH in iPSCs with cell type-specific phenotypes and drug responses. Blood. 2025;145(8):850\u201365. https:\/\/doi.org\/10.1182\/blood.2024026066.","journal-title":"Blood"},{"issue":"16","key":"4379_CR10","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1182\/blood.2019000934","volume":"135","author":"C Rodriguez-Galindo","year":"2020","unstructured":"Rodriguez-Galindo C, Allen CE. Langerhans cell histiocytosis. Blood. 2020;135(16):1319\u201331. https:\/\/doi.org\/10.1182\/blood.2019000934.","journal-title":"Blood"},{"issue":"9","key":"4379_CR11","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1056\/NEJMra1607548","volume":"379","author":"CE Allen","year":"2018","unstructured":"Allen CE, Merad M, McClain KL. Langerhans-Cell Histiocytosis. N Engl J Med. 2018;379(9):856\u201368. https:\/\/doi.org\/10.1056\/NEJMra1607548.","journal-title":"N Engl J Med"},{"issue":"1","key":"4379_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s13023-022-02436-0","volume":"17","author":"HC Cai","year":"2022","unstructured":"Cai HC, Chen J, Liu T, Cai H, Duan MH, Li J, et al. Langerhans cell histiocytosis in adolescent patients: a single-centre retrospective study. Orphanet J Rare Dis. 2022;17(1):268. https:\/\/doi.org\/10.1186\/s13023-022-02436-0.","journal-title":"Orphanet J Rare Dis"},{"issue":"20","key":"4379_CR13","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1182\/blood-2017-08-800565","volume":"130","author":"EC Peckham-Gregory","year":"2017","unstructured":"Peckham-Gregory EC, Chakraborty R, Scheurer ME, Belmont JW, Abhyankar H, Sengal AG, et al. A genome-wide association study of LCH identifies a variant in SMAD6 associated with susceptibility. Blood. 2017;130(20):2229\u201332. https:\/\/doi.org\/10.1182\/blood-2017-08-800565.","journal-title":"Blood"},{"issue":"5","key":"4379_CR14","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1177\/1093526619847859","volume":"22","author":"E Ozer","year":"2019","unstructured":"Ozer E, Sevinc A, Ince D, Yuzuguldu R, Olgun N. BRAF V600E Mutation: A Significant Biomarker for Prediction of Disease Relapse in Pediatric Langerhans Cell Histiocytosis. Pediatr Dev Pathol. 2019;22(5):449\u201355. https:\/\/doi.org\/10.1177\/1093526619847859.","journal-title":"Pediatr Dev Pathol"},{"issue":"1","key":"4379_CR15","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s13023-021-01912-3","volume":"16","author":"S Feng","year":"2021","unstructured":"Feng S, Han L, Yue M, Zhong D, Cao J, Guo Y, et al. Frequency detection of BRAF V600E mutation in a cohort of pediatric langerhans cell histiocytosis patients by next-generation sequencing. Orphanet J Rare Dis. 2021;16(1):272. https:\/\/doi.org\/10.1186\/s13023-021-01912-3.","journal-title":"Orphanet J Rare Dis"},{"issue":"15","key":"4379_CR16","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1182\/bloodadvances.2022008414","volume":"7","author":"JA Whitlock","year":"2023","unstructured":"Whitlock JA, Geoerger B, Dunkel IJ, Roughton M, Choi J, Osterloh L, et al. Dabrafenib, alone or in combination with trametinib, in BRAF V600-mutated pediatric Langerhans cell histiocytosis. Blood Adv. 2023;7(15):3806\u201315. https:\/\/doi.org\/10.1182\/bloodadvances.2022008414.","journal-title":"Blood Adv"},{"key":"4379_CR17","doi-asserted-by":"publisher","unstructured":"Berres ML, Lim KP, Peters T, Price J, Takizawa H, Salmon H, et al. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups [published correction appears in J Exp Med. 2015;212(2):281. https:\/\/doi.org\/10.1084\/jem.2013097701202015c.","DOI":"10.1084\/jem.2013097701202015c"},{"issue":"19","key":"4379_CR18","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1182\/blood-2014-05-577825","volume":"124","author":"R Chakraborty","year":"2014","unstructured":"Chakraborty R, Hampton OA, Shen X, Simko SJ, Shih A, Abhyankar H, et al. Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis. Blood. 2014;124(19):3007\u201315. https:\/\/doi.org\/10.1182\/blood-2014-05-577825.","journal-title":"Blood"},{"key":"4379_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.humpath.2015.12.029","volume":"52","author":"K Alayed","year":"2016","unstructured":"Alayed K, Medeiros LJ, Patel KP, Zuo Z, Li S, Verma S, et al. BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases. Hum Pathol. 2016;52:61\u20137. https:\/\/doi.org\/10.1016\/j.humpath.2015.12.029.","journal-title":"Hum Pathol"},{"issue":"2","key":"4379_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.14735\/amko2018130","volume":"31","author":"O Novosad","year":"2018","unstructured":"Novosad O, Skrypets T, Pastushenko Y, Titorenko I, Martynchyk A, Skachkova O, et al. MAPK\/ERK signal pathway alterations in patients with Langerhans Cell Histiocytosis. Zm\u011bny v sign\u00e1ln\u00ed dr\u00e1ze MAPK\/ERK u pacient\u016f s histiocyt\u00f3zou Langerhansov\u00fdch bun\u011bk. Klin Onkol. 2018;31(2):130\u20136. https:\/\/doi.org\/10.14735\/amko2018130.","journal-title":"Klin Onkol"},{"issue":"4","key":"4379_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.24287\/1726-1708-2023-22-4-102-107","volume":"22","author":"DS Osipova","year":"2023","unstructured":"Osipova DS, Raykina EV, Kozlova YA, Lyudovskikh EI, Evseev DA, Kalinina II, et al. Clinicogenomic associations in patients with Langerhans cell histiocytosis: a cohort study. Pediatr Hematology\/Oncology Immunopathol. 2023;22(4):102\u20137. https:\/\/doi.org\/10.24287\/1726-1708-2023-22-4-102-107.","journal-title":"Pediatr Hematology\/Oncology Immunopathol"},{"issue":"17","key":"4379_CR22","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1182\/blood.2021014343","volume":"139","author":"G Goyal","year":"2022","unstructured":"Goyal G, Tazi A, Go RS, Rech KL, Picarsic JL, Vassallo R, et al. International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults. Blood. 2022;139(17):2601\u201321. https:\/\/doi.org\/10.1182\/blood.2021014343.","journal-title":"Blood"},{"issue":"1","key":"4379_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12105-025-01766-2","volume":"19","author":"RA McKinney","year":"2025","unstructured":"McKinney RA, Wang G. Langerhans Cell Histiocytosis and Other Histiocytic Lesions. Head Neck Pathol. 2025;19(1):26. https:\/\/doi.org\/10.1007\/s12105-025-01766-2.","journal-title":"Head Neck Pathol"},{"issue":"22","key":"4379_CR24","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","volume":"127","author":"JF Emile","year":"2016","unstructured":"Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, et al. Histiocyte Society. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127(22):2672\u201381. https:\/\/doi.org\/10.1182\/blood-2016-01-690636.","journal-title":"Blood"},{"issue":"11","key":"4379_CR25","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.6004\/jnccn.2021.0053","volume":"19","author":"RS Go","year":"2021","unstructured":"Go RS, Jacobsen E, Baiocchi R, Buhtoiarov I, Butler EB, Campbell PK, et al. Histiocytic Neoplasms, version 2.2021. J Natl Compr Canc Netw. 2021;19(11):1277\u2013303. https:\/\/doi.org\/10.6004\/jnccn.2021.0053.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"4379_CR26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41598-021-04526-8","volume":"12","author":"V Belova","year":"2022","unstructured":"Belova V, Pavlova A, Afasizhev R, Moskalenko V, Korzhanova M, Krivoy A, et al. System analysis of the sequencing quality of human whole exome samples on BGI NGS platform. Sci Rep. 2022;12(1):609. https:\/\/doi.org\/10.1038\/s41598-021-04526-8.","journal-title":"Sci Rep"},{"key":"4379_CR27","unstructured":"Andrews S, FastQC:. A quality control tool for high throughput sequence data. 2010. Available online: http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/. Accessed 20 April 2025."},{"key":"4379_CR28","unstructured":"Joint Genome Institute. Available online: https:\/\/jgi.doe.gov\/data-and-tools\/software-tools\/bbtools\/bb-tools-user-guide\/bbduk-guide\/ (accessed on 20 April 2025)."},{"issue":"14","key":"4379_CR29","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows\u2014Wheeler transform. Bioinformatics. 2009;25(14):1754\u201360. 1093\/bioinformatics\/btp324.","journal-title":"Bioinformatics"},{"key":"4379_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp352","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. 1000 Genome Project Data Processing Subgroup. The Sequence Alignment\/Map format and SAMtools. Bioinformatics. 2009;25(16):2078\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btp352."},{"key":"4379_CR31","unstructured":"Picard Toolkit. version 2.22.4; Broad Institute: Cambridge, MA, USA. 2019; Available online: https:\/\/broadinstitute.github.io\/picard\/ (accessed on 20 April 2025)."},{"issue":"21","key":"4379_CR32","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1093\/bioinformatics\/btr509","volume":"27","author":"H Li","year":"2011","unstructured":"Li H. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics. 2011;27(21):2987\u201393. https:\/\/doi.org\/10.1093\/bioinformatics\/btr509.","journal-title":"Bioinformatics"},{"issue":"10","key":"4379_CR33","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nbt.4235","volume":"36","author":"R Poplin","year":"2018","unstructured":"Poplin R, Chang P-C, Alexander D, Schwartz S, Colthurst T, Ku A, et al. A universal SNP and small-indel variant caller using deep neural networks. Nat Biotechnol. 2018;36(10):983\u20137. https:\/\/doi.org\/10.1038\/nbt.4235.","journal-title":"Nat Biotechnol"},{"issue":"13","key":"4379_CR34","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1093\/bioinformatics\/btv112","volume":"31","author":"A Tan","year":"2015","unstructured":"Tan A, Abecasis GR, Kang HM. Unified Representation of Genetic Variants. Bioinformatics. 2015;31(13):2202\u20134. https:\/\/doi.org\/10.1093\/bioinformatics\/btv112.","journal-title":"Bioinformatics"},{"issue":"16","key":"4379_CR35","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H, ANNOVAR. Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164. https:\/\/doi.org\/10.1093\/nar\/gkq603.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"4379_CR36","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ajhg.2017.01.004","volume":"100","author":"Q Li","year":"2017","unstructured":"Li Q, Wang K, InterVar. Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines. Am. J Hum Genet. 2017;100(2):267\u201380. https:\/\/doi.org\/10.1016\/j.ajhg.2017.01.004.","journal-title":"J Hum Genet"},{"issue":"7809","key":"4379_CR37","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434\u201343. https:\/\/doi.org\/10.1038\/s41586-020-2308-7.","journal-title":"Nature"},{"issue":"10","key":"4379_CR38","doi-asserted-by":"publisher","first-page":"nwae326","DOI":"10.1093\/nsr\/nwae326","volume":"11","author":"YA Barbitoff","year":"2024","unstructured":"Barbitoff YA, Khmelkova DN, Pomerantseva EA, Slepchenkov AV, Zubashenko NA, Mironova IV, et al. Expanding the Russian allele frequency reference via cross-laboratory data integration: insights from 7452 exome samples. Natl Sci Rev. 2024;11(10):nwae326. https:\/\/doi.org\/10.1093\/nsr\/nwae326.","journal-title":"Natl Sci Rev"},{"key":"4379_CR39","unstructured":"Database of Population frequencies of genetic variants of the population of the russian federation. [Internet]. FMBA of Russia. 2024. Available online: https:\/\/gdbpop.nir.cspfmba.ru\/. Accessed 20 April 2025."},{"key":"4379_CR40","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C, et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol. 2013;31:213\u20139. https:\/\/doi.org\/10.1038\/nbt.2514.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"4379_CR41","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.acthis.2018.05.002","volume":"120","author":"I Buchwalow","year":"2018","unstructured":"Buchwalow I, Samoilova V, Boecker W, Tiemann M. Multiple immunolabeling with antibodies from the same host species in combination with tyramide signal amplification. Acta Histochem. 2018;120(5):405\u201311. https:\/\/doi.org\/10.1016\/j.acthis.2018.05.002.","journal-title":"Acta Histochem"},{"issue":"2","key":"4379_CR42","doi-asserted-by":"publisher","first-page":"1901190","DOI":"10.1183\/13993003.01190-2019","volume":"55","author":"F Jouenne","year":"2020","unstructured":"Jouenne F, Chevret S, Bugnet E, et al. Genetic landscape of adult Langerhans cell histiocytosis with lung involvement. Eur Respir J. 2020;55(2):1901190. https:\/\/doi.org\/10.1183\/13993003.01190-2019.","journal-title":"Eur Respir J"},{"issue":"2","key":"4379_CR43","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/ahg.12359","volume":"84","author":"X Li","year":"2020","unstructured":"Li X, Liu N, Bai R. Variant frequencies of KCNQ1, KCNH2, and SCN5A in a Chinese inherited arrhythmia cohort and other disease cohorts undergoing genetic testing. Ann Hum Genet. 2020;84(2):161\u20138. https:\/\/doi.org\/10.1111\/ahg.12359.","journal-title":"Ann Hum Genet"},{"issue":"7","key":"4379_CR44","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1182\/blood-2013-12-543793","volume":"124","author":"B Hervier","year":"2014","unstructured":"Hervier B, Haroche J, Arnaud L, Charlotte F, Donadieu J, N\u00e9el A, French Histiocytoses Study Group, et al. Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation. Blood. 2014;124(7):1119\u201326. https:\/\/doi.org\/10.1182\/blood-2013-12-543793.","journal-title":"Blood"},{"issue":"1","key":"4379_CR45","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12902-019-0474-0","volume":"19","author":"W Zhou","year":"2019","unstructured":"Zhou W, Rao J, Li C. Isolated Langerhans cell histiocytosis in the hypothalamic-pituitary region: a case report. BMC Endocr Disord. 2019;19(1):143. https:\/\/doi.org\/10.1186\/s12902-019-0474-0.","journal-title":"BMC Endocr Disord"},{"key":"4379_CR46","doi-asserted-by":"publisher","unstructured":"Savina VYu, Solovyeva SE, Dolzhansky OV, Metelin AV. Clinical and morphological analysis of Langerhans cell histiocytosis in a child of early age. Pirogov Russian J Surg. 2021;6\u20132101\u20134. https:\/\/doi.org\/10.17116\/hirurgia2021062101. (In Russ.).","DOI":"10.17116\/hirurgia2021062101"},{"issue":"1","key":"4379_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/PCR.0000000000000349","volume":"25","author":"Y Pires","year":"2020","unstructured":"Pires Y, Jokerst CE, Panse PM, Kipp BR, Tazelaar HD. Combined Erdheim-Chester Disease and Langerhans Cell Histiocytosis in the Lung: A Report of 2 Patients With Overlap Syndrome. AJSP: Reviews Rep. 2020;25(1):33\u20139. https:\/\/doi.org\/10.1097\/PCR.0000000000000349.","journal-title":"AJSP: Reviews Rep"},{"issue":"4","key":"4379_CR48","doi-asserted-by":"publisher","first-page":"16","DOI":"10.17650\/1818-8346-2022-17-4-16-32","volume":"17","author":"VG Potapenko","year":"2022","unstructured":"Potapenko VG, Baykov VV, Zinchenko AV, Potikhonova NA. Langerhans cell histiocytosis in adults: literature review. Onkogematologiya = Oncohematology. 2022;17(4):16\u201332. https:\/\/doi.org\/10.17650\/1818-8346-2022-17-4-16-32. (In Russ.).","journal-title":"Onkogematologiya = Oncohematology"},{"issue":"2","key":"4379_CR49","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jaad.2009.08.013","volume":"63","author":"JW Tsai","year":"2010","unstructured":"Tsai JW, Tsou JH, Hung LY, Wu HB, Chang KC. Combined Erdheim-Chester disease and Langerhans cell histiocytosis of skin are both monoclonal: a rare case with human androgen-receptor gene analysis. J Am Acad Dermatol. 2010;63(2):284\u201391. https:\/\/doi.org\/10.1016\/j.jaad.2009.08.013.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"4379_CR50","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1053\/j.semdp.2023.05.003","volume":"40","author":"A Auerbach","year":"2023","unstructured":"Auerbach A, Aguilera NS. The changing landscape of pediatric histiocytoses: Birth, life, and transdifferentiation of pediatric histiocyte. Semin Diagn Pathol. 2023;40(6):420\u20138. https:\/\/doi.org\/10.1053\/j.semdp.2023.05.003.","journal-title":"Semin Diagn Pathol"},{"issue":"11","key":"4379_CR51","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.3324\/haematol.2024.286478","volume":"110","author":"F Pegoraro","year":"2025","unstructured":"Pegoraro F, Kondyli M, Prudowsky ZD, van Halteren AGS. Histiocyte Society blueprint for Langerhans cell histiocytosis research: from cell of origin to a more comprehensive cure. Haematologica. 2025;110(11):2588\u2013602. https:\/\/doi.org\/10.3324\/haematol.2024.286478.","journal-title":"Haematologica"},{"issue":"1","key":"4379_CR52","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1046\/j.1365-2249.1999.00950.x","volume":"117","author":"L Misery","year":"1999","unstructured":"Misery L, Rougier N, Crestani B, Faure M, Claudy A, Schmitt D, et al. Presence of circulating abnormal CD34 + progenitors in adult Langerhans cell histiocytosis. Clin Exp Immunol. 1999;117(1):177\u201382. https:\/\/doi.org\/10.1046\/j.1365-2249.1999.00950.x.","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"4379_CR53","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1038\/s41375-025-02656-w","volume":"39","author":"M Tesi","year":"2025","unstructured":"Tesi M, Pegoraro F, Peyronel F, Emile JF, Catamer\u00f2 F, Koster MJ, et al. Cluster analysis reveals the clinical spectrum of Erdheim-Chester disease. Leukemia. 2025;39(8):1987\u201396. https:\/\/doi.org\/10.1038\/s41375-025-02656-w.","journal-title":"Leukemia"},{"issue":"441","key":"4379_CR54","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2157-7633.1000441","volume":"8","author":"PK Raghav","year":"2018","unstructured":"Raghav PK, Gangenahalli G. Hematopoietic Stem Cell Molecular Targets and Factors Essential for Hematopoiesis. J Stem Cell Res Ther. 2018;8(441):2. https:\/\/doi.org\/10.4172\/2157-7633.1000441.","journal-title":"J Stem Cell Res Ther"},{"key":"4379_CR55","doi-asserted-by":"publisher","first-page":"1009160","DOI":"10.3389\/fphys.2022.1009160","volume":"13","author":"B Rix","year":"2022","unstructured":"Rix B, Maduro AH, Bridge KS, Grey W. Markers for human haematopoietic stem cells: The disconnect between an identification marker and its function. Front Physiol. 2022;13:1009160. https:\/\/doi.org\/10.3389\/fphys.2022.1009160.","journal-title":"Front Physiol"},{"issue":"1","key":"4379_CR56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/labinvest.2016.116","volume":"97","author":"DA Chistiakov","year":"2017","unstructured":"Chistiakov DA, Killingsworth MC, Myasoedova VA, Orekhov AN, Bobryshev YV. CD68\/macrosialin: not just a histochemical marker. Lab Invest. 2017;97(1):4\u201313. https:\/\/doi.org\/10.1038\/labinvest.2016.116.","journal-title":"Lab Invest"},{"issue":"2","key":"4379_CR57","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/mi.2015.84","volume":"9","author":"M Duan","year":"2016","unstructured":"Duan M, Steinfort DP, Smallwood D, Hew M, Chen W, Ernst M, et al. CD11b immunophenotyping identifies inflammatory profiles in the mouse and human lungs. Mucosal Immunol. 2016;9(2):550\u201363. https:\/\/doi.org\/10.1038\/mi.2015.84.","journal-title":"Mucosal Immunol"},{"issue":"1","key":"4379_CR58","doi-asserted-by":"publisher","first-page":"5379","DOI":"10.1038\/s41467-018-07387-4","volume":"9","author":"MC Schmid","year":"2018","unstructured":"Schmid MC, Khan SQ, Kaneda MM, Pathria P, Shepard R, Louis TL, et al. Integrin CD11b activation drives anti-tumor innate immunity. Nat Commun. 2018;9(1):5379. https:\/\/doi.org\/10.1038\/s41467-018-07387-4.","journal-title":"Nat Commun"},{"issue":"2","key":"4379_CR59","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/path.1711740202","volume":"174","author":"JF Emile","year":"1994","unstructured":"Emile JF, Fraitag S, Leborgne M, de Prost Y, Brousse N. Langerhans\u2019 cell histiocytosis cells are activated Langerhans\u2019 cells. J Pathol. 1994;174(2):71\u20136. https:\/\/doi.org\/10.1002\/path.1711740202.","journal-title":"J Pathol"},{"issue":"4","key":"4379_CR60","first-page":"1161","volume":"147","author":"JH de Graaf","year":"1995","unstructured":"de Graaf JH, Tamminga RY, Kamps WA, Timens W. Expression of cellular adhesion molecules in Langerhans cell histiocytosis and normal Langerhans cells. Am J Pathol. 1995;147(4):1161\u201371.","journal-title":"Am J Pathol"},{"issue":"17","key":"4379_CR61","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1182\/blood-2017-05-782730","volume":"130","author":"EA Carrera Silva","year":"2017","unstructured":"Carrera Silva EA, Nowak W, Tessone L, Olexen CM, Ortiz Wilczy\u00f1ski JM, Estecho IG, et al. CD207+CD1a+ cells circulate in pediatric patients with active Langerhans cell histiocytosis. Blood. 2017;130(17):1898\u2013902. https:\/\/doi.org\/10.1182\/blood-2017-05-782730.","journal-title":"Blood"},{"issue":"4","key":"4379_CR62","first-page":"193","volume":"9","author":"M Kumar","year":"2015","unstructured":"Kumar M, Updesh Singh Sachdeva M, Naseem S, Ahluwalia J, Das R, Varma N, et al. Bone marrow infiltration in Langerhan\u2019s cell histiocytosis - An unusual but important determinant for staging and treatment. Int J Hematol Oncol Stem Cell Res. 2015;9(4):193\u20137.","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"issue":"25","key":"4379_CR63","doi-asserted-by":"publisher","first-page":"6660","DOI":"10.1182\/blood-2011-01-329011","volume":"118","author":"B Grandchamp","year":"2011","unstructured":"Grandchamp B, Hetet G, Kannengiesser C, Oudin C, Beaumont C, Rodrigues-Ferreira S, et al. A novel type of congenital hypochromic anemia associated with a nonsense mutation in the STEAP3\/TSAP6 gene. Blood. 2011;118(25):6660\u20136. https:\/\/doi.org\/10.1182\/blood-2011-01-329011.","journal-title":"Blood"},{"issue":"8","key":"4379_CR64","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1182\/blood-2015-09-670174","volume":"127","author":"D Liu","year":"2016","unstructured":"Liu D, Yi S, Zhang X, Fang P, Zheng C, Lin L, et al. Human STEAP3 mutations with no phenotypic red cell changes. Blood. 2016;127(8):1067\u201371. https:\/\/doi.org\/10.1182\/blood-2015-09-670174.","journal-title":"Blood"},{"key":"4379_CR65","doi-asserted-by":"publisher","unstructured":"Wang X, Zhou Y, Ning L, Chen J, Chen H, Li X. Knockdown of ANXA10 induces ferroptosis by inhibiting autophagy-mediated TFRC degradation in colorectal cancer [published correction appears. Cell Death Dis. 2023;14(10):683. https:\/\/doi.org\/10.1038\/s41419-023-06151-x.\u00a0","DOI":"10.1038\/s41419-023-06151-x"},{"issue":"2","key":"4379_CR66","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10571-020-00850-1","volume":"41","author":"Y Li","year":"2021","unstructured":"Li Y, Liu Y, Wu P, Tian Y, Liu B, Wang J, et al. Inhibition of Ferroptosis Alleviates Early Brain Injury After Subarachnoid Hemorrhage In Vitro and In Vivo via Reduction of Lipid Peroxidation. Cell Mol Neurobiol. 2021;41(2):263\u201378. https:\/\/doi.org\/10.1007\/s10571-020-00850-1.","journal-title":"Cell Mol Neurobiol"},{"key":"4379_CR67","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fncel.2020.00068","volume":"14","author":"Y Fang","year":"2020","unstructured":"Fang Y, Gao S, Wang X, Cao Y, Lu J, Chen S, et al. Programmed Cell Deaths and Potential Crosstalk With Blood-Brain Barrier Dysfunction After Hemorrhagic Stroke. Front Cell Neurosci. 2020;14:68. https:\/\/doi.org\/10.3389\/fncel.2020.00068.","journal-title":"Front Cell Neurosci"},{"issue":"2\u20133","key":"4379_CR68","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.mam.2013.01.002","volume":"34","author":"N Montalbetti","year":"2013","unstructured":"Montalbetti N, Simonin A, Kovacs G, Hediger MA. Mammalian iron transporters: families SLC11 and SLC40. Mol Aspects Med. 2013;34(2\u20133):270\u201387. https:\/\/doi.org\/10.1016\/j.mam.2013.01.002.","journal-title":"Mol Aspects Med"},{"key":"4379_CR69","doi-asserted-by":"publisher","unstructured":"Mayr R, Janecke AR, Schranz M, Griffiths WJ, Vogel W, Pietrangelo A, et al. Ferroportin disease: a systematic meta-analysis of clinical and molecular findings [published correction appears in J Hepatol. 2011;55(3):734-6. https:\/\/doi.org\/10.1016\/j.jhep.2011.","DOI":"10.1016\/j.jhep.2011"},{"issue":"D1","key":"4379_CR70","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346. https:\/\/doi.org\/10.1093\/nar\/gkac1000.","journal-title":"Nucleic Acids Res"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04379-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04379-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04379-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T02:05:31Z","timestamp":1783303531000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04379-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4379"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04379-2","relation":{"references":[{"id-type":"doi","id":"10.1093\/bioinformatics\/btp352","asserted-by":"subject"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"31 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"According to the institutional policies of the Ethics Committee of Pirogov Russian National Research Medical University, formal ethical approval was not required for this retrospective case report involving analysis of archived clinical data and biological samples. This study was conducted in compliance with local legislation. Written informed consent was obtained from the patient for participation in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of potentially identifiable images or data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"240"}}